Tag Archives: cancer

FDA panel questions Roche’s Tecentriq-Abraxane combo in breast cancer, but votes to keep approval in place for now

The FDA kicked off its three-day meeting on accelerated approvals of immuno-oncology drugs by picking apart one of the biggest players in the field, Roche’s Tecentriq, a PD-L1 inhibitor that the pharma giant has been counting on to replace sales lost to biosimilar competition on other blockbusters. In the end, advisers voted to keep the… Read More »

From Rotten Teeth to Advanced Cancer, Patients Feel the Effects of Treatment Delays

With medical visits picking up again among patients vaccinated against covid-19, health providers are starting to see the consequences of a year of pandemic-delayed preventive and emergency care as they find more advanced cancer and rotting and damaged teeth, among other ailments. Dr. Brian Rah, chair of the cardiology department at Montana’s Billings Clinic, was… Read More »

Merck, Eisai detail Keytruda and Lenvima’s endometrial cancer win in confirmatory study

Merck and Eisai were eager to tout a headline phase 3 win in December for their combination therapy of Keytruda and Lenvima because it involves the regimen’s first FDA-approved indication in endometrial cancer. Now we know how big that win is. Keytruda and Lenvima cut the risk of death by 38% over physician’s choice of… Read More »

Report Links Power Lines to Cancer

After looking at a database of 850 patients diagnosed with lymphatic and bone marrow cancers between 1972 and 1980, researchers from the University of Tasmania and Britain‘s Bristol University found that living near high-voltage power lines might increase the risk of leukemia, lymphoma, and related conditions later in life. People who lived within 328 yards… Read More »